BR112015015229A2 - processo para a preparação de um composto da fórmula, composto, e, invenção - Google Patents

processo para a preparação de um composto da fórmula, composto, e, invenção

Info

Publication number
BR112015015229A2
BR112015015229A2 BR112015015229A BR112015015229A BR112015015229A2 BR 112015015229 A2 BR112015015229 A2 BR 112015015229A2 BR 112015015229 A BR112015015229 A BR 112015015229A BR 112015015229 A BR112015015229 A BR 112015015229A BR 112015015229 A2 BR112015015229 A2 BR 112015015229A2
Authority
BR
Brazil
Prior art keywords
compound
formula
preparation
present
compounds
Prior art date
Application number
BR112015015229A
Other languages
English (en)
Other versions
BR112015015229B1 (pt
BR112015015229A8 (pt
Inventor
She Jin
Chen Junli
Wang Lin
Ren Yi
Original Assignee
Hua Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hua Medicine filed Critical Hua Medicine
Publication of BR112015015229A2 publication Critical patent/BR112015015229A2/pt
Publication of BR112015015229A8 publication Critical patent/BR112015015229A8/pt
Publication of BR112015015229B1 publication Critical patent/BR112015015229B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

1 / 1 resumo “processo para a preparaã‡ãƒo de um composto da fã“rmula, composto, e, invenã‡ãƒo” a presente invenã§ã£o refere-se a um novo processo para a preparaã§ã£o da fã³rmula (i), 1 2 em que r e r sã£o aqui descritos. os compostos preparados pela presente invenã§ã£o sã£o utilizã¡veis na sã­ntese e fabricaã§ã£o de compostos para tratar doenã§as ou condiã§ãµes associadas com a inibiã§ã£o da polimerizaã§ã£o da actina.
BR112015015229-5A 2012-12-25 2013-12-20 processo para a preparação de um composto da fórmula, e, composto BR112015015229B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2012087380 2012-12-25
CNPCT/CN2012/087380 2012-12-25
PCT/EP2013/077563 WO2014102164A1 (en) 2012-12-25 2013-12-20 Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine

Publications (3)

Publication Number Publication Date
BR112015015229A2 true BR112015015229A2 (pt) 2017-07-11
BR112015015229A8 BR112015015229A8 (pt) 2019-10-15
BR112015015229B1 BR112015015229B1 (pt) 2020-07-07

Family

ID=49876646

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015015229-5A BR112015015229B1 (pt) 2012-12-25 2013-12-20 processo para a preparação de um composto da fórmula, e, composto

Country Status (24)

Country Link
US (1) US9388168B2 (pt)
EP (1) EP2938609B1 (pt)
JP (1) JP6297590B2 (pt)
KR (1) KR102122569B1 (pt)
CN (1) CN105051031B (pt)
AU (1) AU2013369473B2 (pt)
BR (1) BR112015015229B1 (pt)
CA (1) CA2896155C (pt)
CY (1) CY1119040T1 (pt)
DK (1) DK2938609T3 (pt)
ES (1) ES2629313T3 (pt)
HK (1) HK1213262A1 (pt)
HR (1) HRP20170653T1 (pt)
HU (1) HUE032621T2 (pt)
IL (1) IL239558A (pt)
LT (1) LT2938609T (pt)
NZ (1) NZ709362A (pt)
PL (1) PL2938609T3 (pt)
PT (1) PT2938609T (pt)
RU (1) RU2621725C2 (pt)
SG (1) SG11201504951TA (pt)
SI (1) SI2938609T1 (pt)
WO (1) WO2014102164A1 (pt)
ZA (1) ZA201504601B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3046861A1 (en) 2016-12-15 2018-06-21 Hua Medicine (Shanghai) Ltd. Oral preparation of glucokinase activator and preparation method therefor
US11813274B2 (en) 2020-04-22 2023-11-14 Hua Medicine (Shanghai) Ltd. Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor
AU2020443475A1 (en) * 2020-04-22 2022-11-17 Hua Medicine (Shanghai) Ltd. Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor
CN111732543A (zh) * 2020-08-14 2020-10-02 浙江鼎龙科技有限公司 一种4,5-二氨基-1-（2-羟乙基）吡唑硫酸盐的制备方法
CN113750100B (zh) * 2021-08-31 2022-12-30 海南中济医药科技有限公司 一种含有多扎格列艾汀与西格列汀的药物组合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160841A (en) * 1977-01-31 1979-07-10 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
FR2748274B1 (fr) * 1996-05-03 1998-06-12 Oreal Nouveaux diamino pyrazoles, leur synthese, compositions de teinture des fibres keratiniques les contenant, procede de teinture des fibres keratiniques
CN101918363B (zh) * 2008-01-18 2012-09-05 安斯泰来制药株式会社 苯乙酰胺衍生物
US7741327B2 (en) * 2008-04-16 2010-06-22 Hoffmann-La Roche Inc. Pyrrolidinone glucokinase activators
US8178689B2 (en) * 2010-06-17 2012-05-15 Hoffman-La Roche Inc. Tricyclic compounds

Also Published As

Publication number Publication date
KR20150100809A (ko) 2015-09-02
PL2938609T3 (pl) 2017-08-31
CN105051031B (zh) 2017-10-10
WO2014102164A1 (en) 2014-07-03
AU2013369473A1 (en) 2015-07-16
PT2938609T (pt) 2017-07-04
SG11201504951TA (en) 2015-07-30
CN105051031A (zh) 2015-11-11
BR112015015229B1 (pt) 2020-07-07
IL239558A0 (en) 2015-08-31
ZA201504601B (en) 2016-10-26
EP2938609B1 (en) 2017-04-12
BR112015015229A8 (pt) 2019-10-15
ES2629313T3 (es) 2017-08-08
CA2896155C (en) 2020-05-05
IL239558A (en) 2017-12-31
HUE032621T2 (en) 2017-10-30
KR102122569B1 (ko) 2020-06-15
CY1119040T1 (el) 2018-01-10
DK2938609T3 (en) 2017-05-15
SI2938609T1 (sl) 2017-07-31
US9388168B2 (en) 2016-07-12
JP2016503812A (ja) 2016-02-08
NZ709362A (en) 2019-07-26
US20150315176A1 (en) 2015-11-05
HK1213262A1 (zh) 2016-06-30
HRP20170653T1 (hr) 2017-06-30
RU2621725C2 (ru) 2017-06-07
CA2896155A1 (en) 2014-07-03
JP6297590B2 (ja) 2018-03-20
RU2015126911A (ru) 2017-01-31
AU2013369473B2 (en) 2017-03-09
LT2938609T (lt) 2017-06-26
EP2938609A1 (en) 2015-11-04

Similar Documents

Publication Publication Date Title
BR112012007085B8 (pt) processos para a preparação de derivados de benzil-benzeno substituídos com glicopiranosila
BR112014013661A2 (pt) Derivados de nucleosídeos 2’,4’-difluoro-2’-metil substituídos como inibidores de replicação de hcv-rna
BR112014008186A2 (pt) método para proteção de plantas úteis ou material de propagação de plantas
BR112018001400A2 (pt) compostos, processo para a síntese dos compostos, composição, utilização de um composto, método para o combate dos fungos e sementes
BR112014009391A2 (pt) dosagem faseada de clopidogrel
CU20130137A7 (es) Derivados de ácido 3- fenilpropiónico ramificados y su uso
BR112015008037A2 (pt) compostos, processo para a preparação de um composto, composição farmacêutica, utilização do composto, método para o tratamento do câncer e invenção
CO6771439A2 (es) Inhibidores de benzodioxano de la producción de leucotrieno
BR112015009395A2 (pt) processo para preparação de derivados do ácido biliar
BR112013000920A2 (pt) compostos para a redução de produção de beta-amiloide
UY33241A (es) ?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?.
BR112015015229A2 (pt) processo para a preparação de um composto da fórmula, composto, e, invenção
BR112013020513A2 (pt) adoçante stevia altamente solúvel
BRPI0813284A8 (pt) Processo para a preparação de um composto da fórmula (i) e composto
BR112015007295A2 (pt) processo para a preparação de compostos; compostos; e uso dos mesmos
BRPI1014802B8 (pt) profármacos de triptolida.
BR112018006519A2 (pt) compostos de fórmula, processo para a síntese de compostos, compostos intermediários x, composição, utilização de um composto de fórmula, método para o combate de fungos e semente
BR112014014046A2 (pt) composto, composição, e, método para tratar hiv
BR112014013098A2 (pt) composições compreendendo ácidos graxos que têm 20 carbonos e métodos de produção e uso dos mesmos
BR112018010140A8 (pt) compostos de fórmula, composição, utilização de um composto de fórmula, método para o combate de fungos fitopatogênicos e semente
BR112012023836A2 (pt) composto tricíclicos e inibidores de pbk contendo os mesmos
BR112013032492A2 (pt) processo para fazer compostos beta-hidroxiamino
BR112014014939A2 (pt) composição de tratamento de sementes
BR112013028486A2 (pt) método para promover crescimento de planta
BR112015021133B8 (pt) mistura de compostos, processo para produzir uma mistura de compostos e limpar superfícies duras ou fibras, formulação aquosa, e, uso de misturas de compostos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/12/2013, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved

Owner name: HUA MEDICINE (SHANGHAI) LTD. (CN)